LOUGHLIN JAMES J
Insider CIK 1276550 · NSPR.OB Director · EDGE Director · CELG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 18,600 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 13,266 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 11,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 20,700 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 300 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 18,600 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 18,600 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 24,666 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 2,068 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 4,756 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer deriv | 2019-11-20 | 2019-11-22 | 970 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 41,861 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | D To issuer | 2019-11-20 | 2019-11-22 | 1,800 | — | $0 | 0 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-15 | 2019-06-17 | 2,066 | — | $0 | 2,068 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-15 | 2019-06-17 | 375 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-15 | 2019-06-17 | 2,066 | — | $0 | 41,861 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-15 | 2019-06-17 | 375 | — | $0 | 39,795 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-14 | 2019-06-17 | 300 | — | $0 | 300 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-14 | 2019-06-17 | 300 | — | $0 | 39,420 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-06-13 | 2019-06-17 | 484 | — | $0 | 970 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-06-13 | 2019-06-17 | 484 | — | $0 | 39,120 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2019-06-03 | 2019-06-05 | 4,756 | — | $0 | 4,756 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 26,625 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2019-02-07 | 2019-02-11 | 24,666 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2019-02-07 | 2019-02-11 | 24,666 | $22.47 | $554.2K | 62,102 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2019-02-07 | 2019-02-11 | 23,466 | $87.29 | $2.05M | 38,636 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-17 | 2018-06-18 | 334 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-17 | 2018-06-18 | 334 | — | $0 | 37,436 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-15 | 2018-06-15 | 375 | — | $0 | 375 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-15 | 2018-06-15 | 2,066 | — | $0 | 4,134 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-15 | 2018-06-15 | 375 | — | $0 | 35,036 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-15 | 2018-06-15 | 2,066 | — | $0 | 37,102 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-14 | 2018-06-15 | 300 | — | $0 | 600 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-14 | 2018-06-15 | 300 | — | $0 | 34,661 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 13,266 | — | $0 | 13,266 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2018-06-13 | 2018-06-15 | 1,454 | — | $0 | 1,454 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-06-04 | 2018-06-05 | 27,750 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2018-06-04 | 2018-06-05 | 17,750 | $78.96 | $1.40M | 34,361 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-06-04 | 2018-06-05 | 27,750 | $30.01 | $832.8K | 52,111 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2018-03-12 | 2018-03-13 | 9,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2018-03-12 | 2018-03-13 | 9,250 | $92.01 | $851.1K | 24,361 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2018-03-12 | 2018-03-13 | 9,250 | $27.18 | $251.4K | 33,611 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-07-01 | 2017-07-05 | 734 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-07-01 | 2017-07-05 | 734 | — | $0 | 24,361 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-06-26 | 2017-06-27 | 9,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-06-26 | 2017-06-27 | 9,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2017-06-26 | 2017-06-27 | 9,250 | $133.57 | $1.24M | 23,627 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-06-26 | 2017-06-27 | 9,250 | $24.97 | $231.0K | 32,877 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-06-26 | 2017-06-27 | 9,250 | $33.88 | $313.4K | 32,877 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2017-06-26 | 2017-06-27 | 9,250 | $133.57 | $1.24M | 23,627 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-21 | 15,000 | $10.15 | $152.3K | 15,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-06-17 | 2017-06-20 | 333 | — | $0 | 334 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-06-17 | 2017-06-20 | 333 | — | $0 | 23,627 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-06-15 | 2017-06-16 | 375 | — | $0 | 750 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-06-15 | 2017-06-16 | 375 | — | $0 | 23,294 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-06-14 | 2017-06-16 | 10,500 | — | $0 | 10,500 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2017-06-14 | 2017-06-16 | 900 | — | $0 | 900 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2017-05-01 | 2017-05-02 | 9,250 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2017-05-01 | 2017-05-02 | 9,250 | $124.00 | $1.15M | 22,919 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2017-05-01 | 2017-05-02 | 9,250 | $28.96 | $267.9K | 32,169 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2017-03-06 | 2017-03-07 | 3,000 | $9.24 | $27.7K | 6,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2016-08-23 | 2016-08-24 | 7,500 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2016-08-23 | 2016-08-24 | 20,000 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2016-08-23 | 2016-08-24 | 20,000 | $26.65 | $533.0K | 42,919 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2016-08-23 | 2016-08-24 | 27,500 | $114.10 | $3.14M | 22,919 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2016-08-23 | 2016-08-24 | 7,500 | $25.58 | $191.8K | 50,419 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2016-07-01 | 2016-07-05 | 733 | — | $0 | 734 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2016-07-01 | 2016-07-05 | 733 | — | $0 | 22,919 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2016-06-17 | 2016-06-17 | 333 | — | $0 | 667 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2016-06-17 | 2016-06-17 | 333 | — | $0 | 22,186 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2016-06-15 | 2016-06-17 | 1,125 | — | $0 | 1,125 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2016-06-15 | 2016-06-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2016-06-12 | 2016-06-13 | 2,068 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2016-06-12 | 2016-06-13 | 2,068 | — | $0 | 21,853 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy deriv | 2016-03-21 | 2016-03-23 | 25,000 | $0.59 | $14.8K | 25,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2016-03-21 | 2016-03-23 | 50,000 | $0.59 | $29.5K | 51,501 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 500 | $7.64 | $3.8K | 613 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 100 | $7.58 | $758 | 100 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 500 | $7.63 | $3.8K | 2,820 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 600 | $7.64 | $4.6K | 2,320 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 1,107 | $7.64 | $8.5K | 1,720 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 180 | $7.63 | $1.4K | 3,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 13 | $7.63 | $99 | 113 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2016-02-22 | 2016-02-24 | 2,100 | $104.12 | $218.7K | 19,785 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 5,000 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 5,409 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 4,875 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 7,500 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 2,500 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | A Award | 2016-01-26 | 2016-01-28 | 1 | — | $0 | 1,501 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 16,774 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 364 | $8.60 | $3.1K | 19,625 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-08 | 7,000 | $11.00 | $77.0K | 19,261 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 12,261 | — | $0 | 12,261 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-09-30 | 2015-10-02 | 95,528 | — | $0 | 95,528 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-07-01 | 2015-07-06 | 733 | — | $0 | 1,467 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-07-01 | 2015-07-06 | 733 | — | $0 | 21,885 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-06-30 | 2015-07-02 | 58,176 | — | $0 | 58,176 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-06-17 | 2015-06-19 | 1,000 | — | $0 | 1,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2015-06-17 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-06-13 | 2015-06-16 | 2,068 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-06-13 | 2015-06-16 | 2,068 | — | $0 | 21,152 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2015-06-12 | 2015-06-16 | 2,066 | — | $0 | 2,068 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2015-06-12 | 2015-06-16 | 2,066 | — | $0 | 19,084 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-03-31 | 2015-04-06 | 51,413 | — | $0 | 51,413 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-01-26 | 2015-01-30 | 54,088 | — | $0 | 54,088 | SEC↗ |
| NSPR InspireMD, Inc. | J Other deriv | 2015-01-05 | 2015-01-07 | 48,745 | — | $0 | 48,745 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-08-22 | 2014-08-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | S Sale | 2014-08-22 | 2014-08-26 | 20,000 | $91.25 | $1.82M | 17,018 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-08-22 | 2014-08-26 | 20,000 | $28.65 | $573.0K | 37,018 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-07-01 | 2014-07-02 | 2,200 | — | $0 | 2,200 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2014-07-01 | 2014-07-02 | 20,700 | — | $0 | 20,700 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-06-13 | 2014-06-16 | 1,033 | — | $0 | 1,034 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-06-13 | 2014-06-16 | 1,033 | — | $0 | 8,509 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2014-06-12 | 2014-06-16 | 1,033 | — | $0 | 2,067 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2014-06-12 | 2014-06-16 | 1,033 | — | $0 | 7,476 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2014-01-29 | 2014-01-31 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-06-16 | 2013-06-17 | 685 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-06-16 | 2013-06-17 | 685 | — | $0 | 6,743 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2013-06-13 | 2013-06-17 | 1,033 | — | $0 | 2,067 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2013-06-13 | 2013-06-17 | 1,033 | — | $0 | 6,058 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-06-12 | 2013-06-14 | 9,300 | — | $0 | 9,300 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2013-06-12 | 2013-06-14 | 3,100 | — | $0 | 3,100 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2013-05-09 | 2013-05-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-04-16 | 2013-04-17 | 15,000 | $2.00 | $30.0K | 15,000 | SEC↗ |
| NSPR.OB InspireMD, Inc. | A Award deriv | 2012-09-21 | 2012-09-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CELG CELGENE CORP /DE/ | P Buy | 2012-06-22 | 2012-06-22 | 600 | $60.29 | $36.2K | 5,025 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2012-06-17 | 2012-06-19 | 685 | — | $0 | 0 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2012-06-17 | 2012-06-19 | 685 | — | $0 | 4,425 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise deriv | 2012-06-16 | 2012-06-19 | 685 | — | $0 | 685 | SEC↗ |
| CELG CELGENE CORP /DE/ | M Exercise | 2012-06-16 | 2012-06-19 | 685 | — | $0 | 3,740 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-06-13 | 2012-06-15 | 9,300 | — | $0 | 9,300 | SEC↗ |
| CELG CELGENE CORP /DE/ | A Award deriv | 2012-06-13 | 2012-06-15 | 3,100 | — | $0 | 3,100 | SEC↗ |